FUJIFILM Europe exhibiting at European Congress of Pathology

                         

 

FUJIFILM Europe will be attending this year’s European Congress of Pathology (ECP) – taking place in Basel, Switzerland, from the 3rd to the 7th of September – where the Medical Informatics team will be showcasing Inspirata’s Dynamyx™ software.   Digital pathology solutions offer significant logistical and operational benefits compared to traditional methods. Digitisation facilitates clinical collaboration across organisations and regions, allowing images and patient data to be shared in real time to create a global community of consultants, educational institutions and specialists, who will have the ability to access shared images, AI and case data in real time. This will help to reduce the time to diagnosis and improve patient outcomes, as well as easing the burden when the demand for histopathologists outstrips the supply.   Dynamyx™ software is a vendor agnostic, end-to-end digital pathology solution, offering an open architecture that can be seamlessly integrated with scanners and LIMS. Dynamyx™ software connects workflow and case management tools with image evaluation and AI solutions. This significantly simplifies the workflow, as everything can be found in one highly functional and user-friendly package. In addition, AI can greatly improve the speed and accuracy of clinical decision making through analysis of objective, quantitative data. Fujifilm supports digital pathology, helping to streamline the transition into the digital era by providing a synergistic portfolio of technologies that help to unify, store, analyse and visualise clinical data.   Tim Wing, Head of Digital Pathology at FUJIFILM Europe, explained: “Fujifilm has been a part of the healthcare industry for a long time, and is now a global player in digital pathology. We are very excited to be exhibiting at ECP, and believe that Dynamyx™ software is an excellent system which, when combined with our complete suite of Fujifilm digital imaging products, will support rapid dissemination of data to clinicians. This will enable faster, more accurate diagnoses and, ultimately, improve patient outcomes.”

FUJIFILM Healthcare Europe to partner with the BOpA Innovation Chair to support advances in the operating room

 

 

FUJIFILM Healthcare Europe is pleased to announce a new partnership with the ‘Augmented Operating Room’ (BOpA) Innovation Chair to accelerate the development of digital technologies for surgery.   The BOpA Innovation Chair – a partnership between Greater Paris University Hospitals | AP-HP, Institut Mines-Télécom (IMT) and Université Paris-Saclay – aims to identify common problems in the operating room, and develop digital technologies to support medical professionals in surgery. The organisation’s purpose is to transform the way surgical procedures are learnt and analysed by modernising resources in theatre.   FUJIFILM Healthcare Europe has agreed a four-year sponsorship to help the BOpA Innovation Chair fund this innovative research. This sponsorship comes in addition to the support provided by the AP‑HP Foundation, Fondation Mines-Télécom and Université Paris-Saclay. As a leading provider of ultrasound systems and software for surgeons, Fujifilm will also participate in the project through the loan of materials and equipment to support the development of these novel technologies to assist in surgery.   Professor Eric Vibert from Université Paris-Saclay, co-founder of the BOpA Innovation Chair and surgeon at the Hepato-Biliary Center of the Paul-Brousse hospital within Greater Paris University Hospitals, said: “The BOpA Innovation Chair is exploring the future of the operating room, so it's no coincidence that Fujifilm is one of BOpA's new sponsors. Between the digital twin and ultra-high frequency ultrasound, we're going to discover what the future will be together”.   Laurent Rapon, Head of Ultrasound Europe at FUJIFILM Healthcare Europe, commented: “Creating new digital technologies to aid surgeons working in the operating room will benefit healthcare systems and patients alike – improving the overall quality of care – and we are delighted to be supporting the BOpA Innovation Chair in this endeavour.”   Françoise Prêteux, Vice-President and General Manager of IMT, added: “The BOpA Chair innovates by cross-fertilizing two major research axes: human-centred approaches and technological advances. As a co-founder, we are pleased to welcome a world-class technology partner to participate in the development of ‘Medicine 4.0’, and improve relationships with patients thanks to digital transformation.”

FUJIFILM presentará nuevas funcionalidades para su plataforma de Mamografía Digital Amulet Innovality para seguir con su lucha vs el cáncer de mama

 FUJIFILM Europe GmbH, una de las empresas más innovadoras en el mercado de equipos médicos y pionera en equipos de Diagnóstico por Imagen, descubrirá las nuevas funcionalidades para su plataforma de Mamografía Digital Amulet Innovality en el 2º Congreso Español de la Mama los próximos días del 22 al 23 de octubre en el Hotel Auditorium de Madrid.

 Fujifilm Corporation, en su particular lucha contra el cáncer de mama y con su compromiso de facilitar los mejores sistemas para dar soporte a la salud de la mujer, presentará las novedades de Amulet Innovality entre las que destacan:

 ü  Biopsia por Tomosíntesis que permite acceder a las lesiones solo visibles en dicha técnica.

ü  Biopsia que opera con todas las aplicaciones mamográficas 2D y 3D (2 modos) reduciendo drásticamente el diagnóstico de falsos positivos.

ü  El equipo cuenta con nuevas paletas adaptativas que hacen posible una notable disminución del dolor durante el estudio.

ü  Dispone de un nuevo sistema optimizado para mejorar la experiencia tanto del usuario como del paciente.

ü  El innovador control de exposimetría automática inteligente se puede utilizar incluso para exploraciones de mamas con implantes.

ü  Nueva versión de su consola de adquisición con nuevas herramientas de QC conforme con los nuevos protocolos.

 Taller de Tomosíntesis, Protocolos y Aplicaciones Avanzadas – viernes 23 de octubre-

Fujifilm, dentro de su programa FABI “Fujifilm Academy Breast Imaging”, organiza el workshop Taller de Tomosíntesis, Protocolos y Aplicaciones Avanzadas donde mostrará casos prácticos seleccionados de Tomosíntesis en dos sesiones el viernes 23 de octubre en la sala Colonia del Hotel Auditorium donde se celebra el Congreso. Las sesiones educativas serán dirigidas por tutores clínicos con experiencia contrastada en turno de mañana de 11:00 a 12:00 y en turno de tarde de 15.00 a 16:00 horas.

 De acuerdo con las necesidades tanto de la detección precoz de cáncer de mama como de la mamografía de diagnóstico, Fujifilm, durante ambas sesiones, facilitará información técnica y evidencia clínica de la aplicación en los diferentes protocolos de adquisición de Tomosíntesis, estando disponibles con Amulet Innovality dos modos de Tomosíntesis, uno con un ángulo estrecho y otro más amplio y a diferentes resoluciones espaciales. Adicionalmente se mostrarán imágenes clínicas de la imagen sintetizada y se mostrará la utilidad de la biopsia por Tomosíntesis.

 El desarrollo de productos de mamografía digital conforme a las nuevas tendencias médicas es una constante en la compañía cuyo objetivo es ayudar a optimizar la labor de los profesionales de la salud.